Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Rheumatoid Arthritis Patients Treated with Abatacept, Rituximab and Tocilizumab in Denmark and Sweden: Risk of Serious Infections

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Harvard

APA

CBE

MLA

Vancouver

Author

Bibtex

@article{58bf524504b2417796737d9de2beb951,
title = "Rheumatoid Arthritis Patients Treated with Abatacept, Rituximab and Tocilizumab in Denmark and Sweden: Risk of Serious Infections",
author = "Gr{\o}n, {Kathrine Lederballe} and Arkema, {E V} and Bente Glintborg and F Mehnert and Mikkel {\O}stergaard and L Dreyer and M N{\o}rgaard and Krogh, {N S} and J Askling and Hetland, {Merete Lund}",
note = "COPECARE",
year = "2018",
language = "English",
volume = "70",
journal = "Arthritis & Rheumatology",
issn = "1537-2960",
publisher = "eMedguides.com",
number = "S9",

}

RIS

TY - ABST

T1 - Rheumatoid Arthritis Patients Treated with Abatacept, Rituximab and Tocilizumab in Denmark and Sweden: Risk of Serious Infections

AU - Grøn, Kathrine Lederballe

AU - Arkema, E V

AU - Glintborg, Bente

AU - Mehnert, F

AU - Østergaard, Mikkel

AU - Dreyer, L

AU - Nørgaard, M

AU - Krogh, N S

AU - Askling, J

AU - Hetland, Merete Lund

N1 - COPECARE

PY - 2018

Y1 - 2018

M3 - Conference abstract in journal

VL - 70

JO - Arthritis & Rheumatology

JF - Arthritis & Rheumatology

SN - 1537-2960

IS - S9

M1 - 227

ER -

ID: 56612803